Big Data

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade…

1 year ago

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals

The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application REHOVOT, Israel, Sept.…

1 year ago

Superluminal Medicines Announces Formation of Scientific Advisory Board

Multidisciplinary board members bring expertise in drug discovery, clinical development, computational life science, GPCRs and drug formulationBOSTON, Sept. 30, 2024…

1 year ago

Global Health Exhibition to Showcase Unique Advances in AI-Enabled Diagnostics and Patient Care

The event's Digital Health Forum will reveal the world's latest developments in artificial intelligence (AI) enabled diagnostic decision-making for an…

1 year ago

XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP

BOSTON and SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- Today, XtalPi announced the official launch of XFEP and XMolGen, two proprietary…

1 year ago

Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation

HFX AdaptivAI combines insights from over 100,000 patients and more than 100 million data points¹ and leverages artificial intelligence (AI) to deliver…

1 year ago

INOVAIT and the Government of Canada announce the latest recipients of the INOVAIT Pilot Fund for advancements in image-guided therapy and artificial intelligence

TORONTO, Sept. 23, 2024 /PRNewswire/ - INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and…

1 year ago

RadiantGraph Adds Cloud Integrations to Accelerate Personalization and Consumer Engagement for Health Plans

AI has shown success in helping health plans hyper-personalize communications, engage consumers, improve outcomes and CAHPS and star ratingsHowever, the…

1 year ago

BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia Submitted protocol to FDA…

1 year ago

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event…

1 year ago